Theranostics Market Size, Share, and Outlook, H2-2025 Report- By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals
Description
Theranostics Market Outlook
The global Theranostics Market Size is valued at $2.6 Billion in 2025 and is forecast to reach $6.8 Billion in 2032 at a CAGR of 14.8%.
The Theranostics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Theranostics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Theranostics Market Insights, 2025
The theranostics market is rapidly evolving with the convergence of diagnostic imaging and targeted therapeutics for personalized medicine. Recent advancements include radiopharmaceuticals for cancer imaging and therapy, companion diagnostics, and molecular imaging probes. Companies are focusing on precision oncology and patient stratification to improve treatment efficacy. Growth is driven by the increasing prevalence of cancer, neurological disorders, and rare diseases. Regulatory approvals for novel theranostic agents and imaging technologies are facilitating market adoption. Integration with AI, big data analytics, and precision medicine platforms enhances patient outcomes. Research is emphasizing multi-modal theranostic agents combining therapy and real-time monitoring. Overall, the market highlights innovation, personalized treatment, and clinical efficiency.
Five Trends Shaping the Global Theranostics Market in 2025 and Beyond
The global Theranostics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Theranostics Industry?
The Theranostics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Theranostics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Theranostics Market Segment Insights
The Theranostics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Theranostics Industry Value Chain
The chapter identifies potential companies and their operations across the global Theranostics Industry ecosystem. It assists decision-makers in evaluating global Theranostics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Theranostics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Theranostics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Theranostics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Theranostics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Theranostics Market.
Europe Theranostics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Theranostics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Theranostics Industry competitiveness. The report analyses the key Theranostics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Theranostics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Theranostics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Theranostics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Theranostics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Theranostics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Theranostics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Acrotech Biopharma LLC, Advanced Accelerator Applications SA, Bayer AG, Canon Inc, Cardinal Health Inc, Curium Pharma, Eckert & Ziegler AG, Eczacıbaşı-Monrol Nuclear Products Co., GE Healthcare, Lantheus Holdings Inc, NorthStar Medical Radioisotopes LLC, Pharmalogic Holdings Corp, Philips Healthcare, Siemens Healthineers AG. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Theranostics Market Scope
Leading Segments
By Product
Diagnostic Imaging
Radiopharmaceuticals
IVD/Biomarker Screening
Software and Services
By Application
Prostate Cancer
Bone Metastasis
Others
Others
By End-User
Hospitals and Cancer Care Centers
Theranostics Centers
Research and Academic Centers
Leading Companies
Acrotech Biopharma LLC
Advanced Accelerator Applications SA
Bayer AG
Canon Inc
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler AG
Eczacıbaşı-Monrol Nuclear Products Co.
GE Healthcare
Lantheus Holdings Inc
NorthStar Medical Radioisotopes LLC
Pharmalogic Holdings Corp
Philips Healthcare
Siemens Healthineers AG
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Theranostics Market Size is valued at $2.6 Billion in 2025 and is forecast to reach $6.8 Billion in 2032 at a CAGR of 14.8%.
The Theranostics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Theranostics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Theranostics Market Insights, 2025
The theranostics market is rapidly evolving with the convergence of diagnostic imaging and targeted therapeutics for personalized medicine. Recent advancements include radiopharmaceuticals for cancer imaging and therapy, companion diagnostics, and molecular imaging probes. Companies are focusing on precision oncology and patient stratification to improve treatment efficacy. Growth is driven by the increasing prevalence of cancer, neurological disorders, and rare diseases. Regulatory approvals for novel theranostic agents and imaging technologies are facilitating market adoption. Integration with AI, big data analytics, and precision medicine platforms enhances patient outcomes. Research is emphasizing multi-modal theranostic agents combining therapy and real-time monitoring. Overall, the market highlights innovation, personalized treatment, and clinical efficiency.
Five Trends Shaping the Global Theranostics Market in 2025 and Beyond
The global Theranostics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Theranostics Industry?
The Theranostics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Theranostics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Theranostics Market Segment Insights
The Theranostics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Theranostics Industry Value Chain
The chapter identifies potential companies and their operations across the global Theranostics Industry ecosystem. It assists decision-makers in evaluating global Theranostics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Theranostics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Theranostics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Theranostics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Theranostics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Theranostics Market.
Europe Theranostics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Theranostics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Theranostics Industry competitiveness. The report analyses the key Theranostics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Theranostics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Theranostics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Theranostics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Theranostics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Theranostics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Theranostics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Acrotech Biopharma LLC, Advanced Accelerator Applications SA, Bayer AG, Canon Inc, Cardinal Health Inc, Curium Pharma, Eckert & Ziegler AG, Eczacıbaşı-Monrol Nuclear Products Co., GE Healthcare, Lantheus Holdings Inc, NorthStar Medical Radioisotopes LLC, Pharmalogic Holdings Corp, Philips Healthcare, Siemens Healthineers AG. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Theranostics Market Scope
Leading Segments
By Product
Diagnostic Imaging
Radiopharmaceuticals
IVD/Biomarker Screening
Software and Services
By Application
Prostate Cancer
Bone Metastasis
Others
Others
By End-User
Hospitals and Cancer Care Centers
Theranostics Centers
Research and Academic Centers
Leading Companies
Acrotech Biopharma LLC
Advanced Accelerator Applications SA
Bayer AG
Canon Inc
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler AG
Eczacıbaşı-Monrol Nuclear Products Co.
GE Healthcare
Lantheus Holdings Inc
NorthStar Medical Radioisotopes LLC
Pharmalogic Holdings Corp
Philips Healthcare
Siemens Healthineers AG
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
189 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Theranostics Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Theranostics Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Theranostics Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Theranostics Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Theranostics Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software and Services
- By Application
- Prostate Cancer
- Bone Metastasis
- Others
- Others
- By End-User
- Hospitals and Cancer Care Centers
- Theranostics Centers
- Research and Academic Centers
- 6. Global Theranostics Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Theranostics Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Theranostics Market Trends and Growth Opportunities
- 6.2.1 North America Theranostics Market Outlook by Type
- 6.2.2 North America Theranostics Market Outlook by Application
- 6.3 North America Theranostics Market Outlook by Country
- 6.3.1 The US Theranostics Market Outlook, 2021- 2032
- 6.3.2 Canada Theranostics Market Outlook, 2021- 2032
- 6.3.3 Mexico Theranostics Market Outlook, 2021- 2032
- 7. Europe Theranostics Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Theranostics Market Trends and Growth Opportunities
- 7.2.1 Europe Theranostics Market Outlook by Type
- 7.2.2 Europe Theranostics Market Outlook by Application
- 7.3 Europe Theranostics Market Outlook by Country
- 7.3.2 Germany Theranostics Market Outlook, 2021- 2032
- 7.3.3 France Theranostics Market Outlook, 2021- 2032
- 7.3.4 The UK Theranostics Market Outlook, 2021- 2032
- 7.3.5 Spain Theranostics Market Outlook, 2021- 2032
- 7.3.6 Italy Theranostics Market Outlook, 2021- 2032
- 7.3.7 Russia Theranostics Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Theranostics Market Outlook, 2021- 2032
- 8. Asia Pacific Theranostics Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Theranostics Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Theranostics Market Outlook by Type
- 8.2.2 Asia Pacific Theranostics Market Outlook by Application
- 8.3 Asia Pacific Theranostics Market Outlook by Country
- 8.3.1 China Theranostics Market Outlook, 2021- 2032
- 8.3.2 India Theranostics Market Outlook, 2021- 2032
- 8.3.3 Japan Theranostics Market Outlook, 2021- 2032
- 8.3.4 South Korea Theranostics Market Outlook, 2021- 2032
- 8.3.5 Australia Theranostics Market Outlook, 2021- 2032
- 8.3.6 South East Asia Theranostics Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Theranostics Market Outlook, 2021- 2032
- 9. South America Theranostics Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Theranostics Market Trends and Growth Opportunities
- 9.2.1 South America Theranostics Market Outlook by Type
- 9.2.2 South America Theranostics Market Outlook by Application
- 9.3 South America Theranostics Market Outlook by Country
- 9.3.1 Brazil Theranostics Market Outlook, 2021- 2032
- 9.3.2 Argentina Theranostics Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Theranostics Market Outlook, 2021- 2032
- 10. Middle East and Africa Theranostics Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Theranostics Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Theranostics Market Outlook by Type
- 10.2.2 Middle East and Africa Theranostics Market Outlook by Application
- 10.3 Middle East and Africa Theranostics Market Outlook by Country
- 10.3.1 Saudi Arabia Theranostics Market Outlook, 2021- 2032
- 10.3.2 The UAE Theranostics Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Theranostics Market Outlook, 2021- 2032
- 10.3.4 South Africa Theranostics Market Outlook, 2021- 2032
- 10.3.5 Egypt Theranostics Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Theranostics Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Acrotech Biopharma LLC
- Advanced Accelerator Applications SA
- Bayer AG
- Canon Inc
- Cardinal Health Inc
- Curium Pharma
- Eckert & Ziegler AG
- Eczacıbaşı-Monrol Nuclear Products Co.
- GE Healthcare
- Lantheus Holdings Inc
- NorthStar Medical Radioisotopes LLC
- Pharmalogic Holdings Corp
- Philips Healthcare
- Siemens Healthineers AG
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
